Thiol/disulfide homeostasis and ischemia modified albumin levels in autoimmune gastritis and their relations with gastric emptying

Background/aim: Autoimmune gastritis is an autoimmune and inflammatory disorder. The aim of this study is to examine dynamic thiol/disulfide homeostasis and ischemia modified albumin levels, and to analyze the association between thiol/disulfide homeostasis and gastric emptying time in autoimmune gastritis. Materials and methods: Thiol/disulfide homeostasis tests and ischemia modified albumin levels were determined in 50 autoimmune gastritis patients and 53 healthy subjects. Patients with delayed and normal gastric emptying were compared by thiol/disulfide homeostasis tests. Results: The results showed that native thiol μmol/L , total thiol μmol/L , and native thiol/total thiol ratio % of the patients with autoimmune gastritis decreased compared to the control group 177.7 ± 34.18 vs. 245.25 ± 33.83, P = 0.001, 227.25 ± 36.78 vs. 284.20 ± 27.19, P = 0.03, and 8.84 ± 1.1 vs. 7.74% ± 1.3%, P = 0.001 . In addition, native thiol μmol/L , total thiol μmol/L , and native thiol/total thiol ratio % were found to be lower in patients with delayed gastric emptying 198.65 ± 24.27 vs. 167.12 ± 20.51, 241.81 ± 27.14 vs. 213.92 ± 26.35, 8.34 ± 1.29 vs. 7.20 ± 1.83, P = 0.001 . Disulfide level, disulfide/native thiol, disulfide/total thiol P = 0.001 ratios, and ischemia modified albumin levels ABSU, 0.71 ± 0.08 vs. 0.83 ± 0.07 were found to be higher in autoimmune gastritis patients with delayed gastric emptying P = 0.001 . Conclusion: The results showed that thiol/disulfide homeostasis in patients with autoimmune gastritis caused an increase in ischemia modified albumin and disulfide whereas a decrease in thiols. An altered thiol/disulfide balance was also observed in patients with delayed gastric emptying. These results suggest that the oxidative process is involved in patients with autoimmune gastritis.

___

  • 1. Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis—pathogenesis, pathology and management. Nature Reviews Gastroenterology & Hepatology. 2013; 10 (9): 529-541. doi: 10.1038/nrgastro.2013.101
  • 2. Ates I, Altay M, Yilmaz FM, Topcuoglu C, Neselioglu S et al. Dynamic thiol/disulfide homeostasis in patients with autoimmune subclinical hypothyroidism. Endocrine Research 2016; 41 (4): 343-349. doi: 10.3109/07435800.2016.1156124
  • 3. Dogru A, Balkarli A, Cetin GY, Neselioglu S, Erel O et al. Thiol/ disulfide homeostasis in patients with ankylosing spondylitis. Bosnian Journal of Basic Medical Sciences 2016; 16 (3): 187- 192. doi: 10.17305/bjbms.2016.1001
  • 4. Sahin A, Erten S, Altunoglu A, Isikoglu S, Neselioglu S et al. Comparison of serum oxidant and antioxidant parameters in familial Mediterranean fever patients (FMF) with attack free period. Acta Reumatologica Portuguesa 2014; 39 (4): 316-321.
  • 5. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet 1984; 1 (8391): 1396-1397. doi: 10.1016/s0140-6736(84)91886-5
  • 6. Kayalı R, Cakatay U. Protein oksidasyonunun ana mekanizmaları. Cerrahpasa Journal of Medicine 2002; 35: 83- 89 (in Turkish).
  • 7. Sen CK, Packer L. Thiol homeostasis and supplements in physical exercise. American Journal of Clinical Nutrition 2000; 72 (2 Suppl.): 653-669. doi: 10.1093/ajcn/72.2.653S
  • 8. Cremers CM, Jakob U. Oxidant sensing by reversible disulfide bond formation. Journal of Biological Chemistry 2013; 288 (37): 26489-26496. doi: 10.1074/jbc.R113.462929
  • 9. Turell L, Radi Ralvarez B. The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radical Biology & Medicine 2013; 65: 244-253. doi: 10.1016/j. freeradbiomed.2013.05.050
  • 10. Biswas S, Chida AS, Rahman I. Redox modifications of protein thiols: emerging roles in cell signaling. Biochemical Pharmacology 2006; 71 (5): 551-564. doi: 10.1016/j. bcp.2005.10.044
  • 11. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biology & Medicine 2010; 48 (6): 749-762. doi: 10.1016/j.freeradbiomed.2009.12.022
  • 12. Valle Gottlieb MG, da Cruz IB, Duarte MM, Moresco RN, Wiehe M et al. Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkers. Journal of Clinical Endocrinology & Metabolism 2010; 95 (2): 586-591. doi: 10.1210/jc.2009-1592
  • 13. Wudkowska A, Goch J, Goch A. Ischemia−modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris. Kardiologia Polska 2010; 68 (4): 431-437.
  • 14. Erel O, Neselioglu S. A novel and automated assay for thiol/ disulphide homeostasis. Clinical Biochemistry 2014; 47 (18): 326-332. doi: 10.1016/j.clinbiochem.2014.09.026
  • 15. Pavithran P, Nandeesha H, Sathiyapriya V, Bobby Z, Madanmohan T. Short term heart variability and oxidative stress in newly diagnosed essential hypertension. Clinical and Experimental Hypertension 2008; 30 (7): 486-496. doi: 10.1080/10641960802251875
  • 16. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine Reviews 2004; 25 (4): 612-628. doi: 10.1210/er.2003-0019
  • 17. Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004; 27 (9): 2178-2183. doi: 10.2337/ diacare.27.9.2178
  • 18. Kalkan C, Soydal C, Ozkan E, Maden A, Soykan I. Relationships between autonomic nerve function and gastric emptying in patients with autoimmune gastritis. Clinical Autonomic Research 2016; 26 (3): 189-196. doi: 10.1007/s10286-016- 0353-y
  • 19. Kalkan C, Soykan I, Soydal C, Ozkan E, Kalkan E. Assessment of gastric emptying in patients with autoimmune gastritis. Digestive Disease and Sciences 2016; 61 (6): 1597-1602. doi: 10.1007/s10620-015-4021-1
  • 20. Kalkan G, Emre S, Alisik M, Aktas A, Baran P. Dynamic thiol/ disulfide homeostasis in patients with lichen planus. Journal of Clinical Laboratory Analysis 2019 Jan; 33 (1): e22642. doi:10.1002/jcla.22642
  • 21. Ünal K, Erzin G, Yuksel RN, Alisik M, Erel O. Thiol/disulphide homeostasis in schizophrenia patients with positive symptoms. Nordic Journal of Psychiatry 2018; 72 (4): 281-284. doi: 10.1080/08039488.2018.1441906
  • 22. Sener S, Akbas A, Kilinc F, Baran P, Erel O et al. Thiol/ disulfide homeostasis as a marker of oxidative stress in rosacea: a controlled spectrophotometric study. Cutaneous Ocular Toxicology 2019 Mar; 38 (1): 55-58. doi: 10.1080/15569527.2018.1517124
  • 23. Köseoğlu H, Alisik M, Basaran M, Yurekli OT, Solakoglu T et al. Dynamic thiol/disulphide homeostasis in acute pancreatitis. Turkish Journal of Gastroenterology 2018; 29 (3): 348-353. doi: 10.5152/tjg.2018.17499
  • 24. Ivanov AI, Korolenko EA, Korolik EV, Firsov SP, Zhbankov RG et al. Chronic liver and renal diseases differently affect structure of human serum albumin. Archives of Biochemistry and Biophysics 2002; 408: 69-77. doi: 10.1016/s0003- 9861(02)00533-7
  • 25. Du Y, Su T, Song X, Gao J, Zou D et al. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome–predominant functional dyspepsia. Journal of Clinical Gastroenterology 2014; 48 (4): 328-335. doi: 10.1097/MCG.0000000000000033
  • 26. Yuksel M, Ates I, Kaplan M, Alisik M, Erel O et al. The dynamic thiol/disulphide homeostasis in inflammatory bowel disease and its relation with disease activity and pathogenesis. International Journal of Colorectal Disease 2016; 31: 1229- 1231. doi: 10.1007/s00384-015-2439-8
  • 27. Ates¸ I, Ozkayar N, Altay M, Yilmaz FM, Topcuoglu C et al. Is disulphide/thiol ratio related to blood pressure in masked hypertension? Clinical and Experimental Hypertension 2016; 38: 150-154. doi: 10.3109/10641963.2015.1060995
  • 28. Ates I, Kaplan M, Yuksel M, Mese D, Alisik M et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016; 51 (1): 47-51. doi: 10.1007/s12020- 015-0784-6
  • 29. Kundi H, Ates I, Kiziltunc E, Cetin M, Cicekcioglu H et al. A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. American Journal of Emergency Medicine 2015; 33: 1567-1571. doi: 10.1016/j.ajem.2015.06.016
  • 30. Nanda N, Bobby Z, Hamide A. Oxidative stress in anti thyroperoxidase antibody positive hypothyroid patient. Asian Journal of Biochemistry 2012; 7: 54-58.
  • 31. Ates I, Yilmaz FM, Altay M, Yilmaz N, Berker D et al. The Relationship between Oxidative Stress and Autoimmunity in Hashimoto’s Thyroiditis. European Journal of Endocrinology 2015; 173: 791-799. doi: 10.1530/EJE-15-0617
  • 32. Baser H, Can U, Baser S, Yerlikaya FH, Aslan U et al. Assesment of oxidative status and its association with thyroid autoantibodies in patients with euthyroid autoimmune thyroiditis. Endocrine 2015; 48 (3): 916-923. doi:10.1007/s12020-014-0399-3
  • 33. Kurien BT, Scofield H. Autoimmunity and oxidatively modified autoantigens. Autoimmunity Reviews 2008; 7: 567-573. doi: 10.1016/j.autrev.2008.04.019
  • 34. Kaplan M, Ates I, Yuksel M, Ozin YO, Alisik M et al. Thiol/ disulphide homeostasis in celiac disease. World Journal of Gastrointestinal Pharmacology and Therapeutics 2017 6; 8 (2): 120-126. doi: 10.4292/wjgpt.v8.i2.120
  • 35. Thiyagarajan R, Pal P, Pal GK, Subramanian SK, Bobby Z et al. Cardiovagal modulation, oxidative stress, and cardiovascular risk factors in prehypertensive subjects: cross-sectional study. American Journal of Hypertension 2013; 26 (7): 850–857. doi: 10.1093/ajh/hpt025
  • 36. Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004; 27 (9): 2178-2183. doi: 10.2337/ diacare.27.9.2178
  • 37. Balta S, Aparci M, Demir M, Ozturk C, Celik T. Ischemiamodified albumin in patients with seizure. American Journal of Emergency Medicine 2014; 32 (10): 1282. doi: 10.1016/j. ajem.2014.06.028
  • 38. Piva SJ, Duarte MM, Da Cruz IB, Coelho AC, Moreira AP et al. Ischemia-modified albumin as an oxidative stress biomarker in obesity. Clinical Biochemistry 2011; 44 (4): 345-347. doi: 10.1016/j.clinbiochem.2010.12.001
  • 39. Caglar GS, Oztas E, Karadag D, Pabuccu R, Demirtas S. Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance. Fertility and Sterility 2011; 95 (1): 310-313. doi: 10.1016/j. fertnstert.2010.06.092
  • 40. Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clinical Biochemistry 2009; 42 (7-8): 666-671. doi: 10.1016/j. clinbiochem.2009.01.010
  • 41. Kucuk A, Uslu AU, Arslan S, Balta S, Ozturk C et al. Ischemiamodified albumin and atherosclerosis in patients with familial mediterranean fever. Angiology 2016; 67 (5): 456-460. doi: 10.1177/0003319715595744
  • 42. Capkin E, Karkucak M, Kola M, Karaca A, Capkin AA et al. Ischemia-modified albumin (IMA): A novel marker of vascular involvement in Behcet’s disease? Joint Bone Spine 2015; 82 (1): 68-69. doi: 10.1016/j.jbspin.2014.06.007
  • 43. Majdalawieh AF, Mansour ZR. Sesamol, a major lignan in sesame seeds (Sesamum indicum): Anti-cancer properties and mechanisms of action. European Journal of Pharmacology 2019; 855: 75-89. doi: 10.1016/j.ejphar.2019.05.008
  • 44. Ismail M, Hasan H, El-Orfali Y, Ismail H, Khawaja G. Anti-inflammatory, antioxidative, and hepatoprotective effects of trans Δ9-tetrahydrocannabinol/sesame oil on adjuvant-induced arthritis in rats. Evidence-Based Complementary and Alternative Medicine 2018; 9365464. doi: 10.1155/2018/9365464